CA Stock MarketDetailed Quotes

INNO InnoCan Pharma Corp

Watchlist
  • 0.230
  • 0.0000.00%
15min DelayMarket Closed Nov 1 09:30 ET
65.71MMarket Cap-10952P/E (TTM)

InnoCan Pharma Corp Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
176.96%8.64M
333.85%6.77M
433.69%13.66M
331.10%4.89M
445.13%4.08M
652.05%3.12M
500.00%1.56M
1,205.61%2.56M
6,993.75%1.14M
1,287.04%749K
Operating revenue
176.96%8.64M
333.85%6.77M
433.69%13.66M
331.10%4.89M
445.13%4.08M
652.05%3.12M
500.00%1.56M
1,205.61%2.56M
6,993.75%1.14M
1,287.04%749K
Cost of revenue
38.92%646K
303.68%767K
271.46%1.68M
1,676.47%604K
1,132.35%419K
131.34%465K
4.40%190K
502.67%452K
466.67%34K
47.83%34K
Gross profit
201.13%8M
338.03%6M
468.49%11.98M
289.55%4.29M
412.45%3.66M
1,141.12%2.66M
1,656.41%1.37M
1,641.32%2.11M
10,910.00%1.1M
2,206.45%715K
Operating expense
141.46%7.47M
173.63%7.21M
88.47%15.78M
106.49%5.18M
174.37%4.87M
41.12%3.09M
38.96%2.64M
10.16%8.37M
9.94%2.51M
7.25%1.78M
Selling and administrative expenses
148.36%7.04M
234.10%6.79M
104.25%13.99M
117.32%4.68M
187.69%4.44M
63.78%2.84M
43.10%2.03M
10.40%6.85M
9.18%2.15M
6.86%1.54M
-Selling and marketing expense
168.20%5.95M
313.16%4.99M
265.54%10.47M
276.56%3.81M
350.91%3.23M
179.60%2.22M
253.22%1.21M
103.84%2.86M
101.80%1.01M
296.13%717K
-General and administrative expense
76.75%1.09M
118.20%1.8M
-11.72%3.52M
-23.64%872K
46.00%1.21M
-34.36%615K
-23.56%824K
-16.97%3.98M
-22.37%1.14M
-34.60%826K
Research and development costs
65.37%425K
-29.80%424K
17.69%1.8M
41.18%504K
85.78%431K
-44.13%257K
26.62%604K
9.08%1.53M
14.79%357K
9.95%232K
Operating profit
222.02%532K
4.27%-1.21M
39.31%-3.8M
36.55%-894K
-13.77%-1.21M
77.95%-436K
30.40%-1.27M
16.23%-6.27M
38.01%-1.41M
34.73%-1.06M
Net non-operating interest income (expenses)
50.00%3K
-155.56%-5K
21.05%23K
150.00%15K
-142.86%-3K
-81.82%2K
280.00%9K
246.15%19K
146.15%6K
7K
Non-operating interest income
0.00%3K
--0
9.52%23K
62.50%13K
--0
-72.73%3K
--10K
--21K
--8K
--7K
Non-operating interest expense
----
400.00%5K
--0
-200.00%-2K
--3K
--1K
-80.00%1K
-84.62%2K
--2K
--0
Other net income (expenses)
2,265.79%899K
-110.34%-3K
-110.77%-254K
26.92%297K
-169.36%-618K
-72.66%38K
-97.35%29K
190.80%2.36M
-86.08%234K
144.35%891K
Gain on sale of security
2,265.79%899K
-110.34%-3K
-110.77%-254K
26.92%297K
-169.36%-618K
-72.66%38K
-97.35%29K
190.80%2.36M
-86.08%234K
144.35%891K
Income before tax
462.12%1.43M
0.65%-1.22M
-3.76%-4.03M
50.21%-582K
-1,027.78%-1.83M
78.33%-396K
-68.45%-1.23M
61.47%-3.89M
-93.22%-1.17M
95.54%-162K
Income tax
478K
234K
21,300.00%214K
21,300.00%214K
0
0
0
1K
1K
0
Earnings from equity interest net of tax
Net income
341.41%956K
-18.40%-1.45M
-9.23%-4.25M
31.97%-796K
-1,027.78%-1.83M
78.33%-396K
-68.45%-1.23M
61.46%-3.89M
-93.39%-1.17M
95.54%-162K
Net income continuous operations
341.41%956K
-18.40%-1.45M
-9.23%-4.25M
31.97%-796K
-1,027.78%-1.83M
78.33%-396K
-68.45%-1.23M
61.46%-3.89M
-93.39%-1.17M
95.54%-162K
Noncontrolling interests
399.19%619K
645.24%313K
461.60%452K
135.14%87K
3,233.33%200K
236.26%124K
153.85%42K
-184.09%-125K
212.12%37K
154.55%6K
Net income attributable to the company
164.81%337K
-39.13%-1.77M
-24.87%-4.7M
26.84%-883K
-1,106.55%-2.03M
70.05%-520K
-95.08%-1.27M
62.54%-3.76M
-111.01%-1.21M
95.36%-168K
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders
164.81%337K
-39.13%-1.77M
-24.87%-4.7M
26.84%-883K
-1,106.55%-2.03M
70.05%-520K
-95.08%-1.27M
62.54%-3.76M
-111.01%-1.21M
95.36%-168K
Diluted earnings per share
150.00%0.001
0.00%-0.005
-6.25%-0.017
40.00%-0.003
-600.00%-0.007
71.43%-0.002
-66.67%-0.005
68.00%-0.016
16.67%-0.005
93.75%-0.001
Basic earnings per share
150.00%0.001
0.00%-0.005
-6.25%-0.017
40.00%-0.003
-600.00%-0.007
71.43%-0.002
-66.67%-0.005
68.00%-0.016
16.67%-0.005
93.75%-0.001
Dividend per share
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue 176.96%8.64M333.85%6.77M433.69%13.66M331.10%4.89M445.13%4.08M652.05%3.12M500.00%1.56M1,205.61%2.56M6,993.75%1.14M1,287.04%749K
Operating revenue 176.96%8.64M333.85%6.77M433.69%13.66M331.10%4.89M445.13%4.08M652.05%3.12M500.00%1.56M1,205.61%2.56M6,993.75%1.14M1,287.04%749K
Cost of revenue 38.92%646K303.68%767K271.46%1.68M1,676.47%604K1,132.35%419K131.34%465K4.40%190K502.67%452K466.67%34K47.83%34K
Gross profit 201.13%8M338.03%6M468.49%11.98M289.55%4.29M412.45%3.66M1,141.12%2.66M1,656.41%1.37M1,641.32%2.11M10,910.00%1.1M2,206.45%715K
Operating expense 141.46%7.47M173.63%7.21M88.47%15.78M106.49%5.18M174.37%4.87M41.12%3.09M38.96%2.64M10.16%8.37M9.94%2.51M7.25%1.78M
Selling and administrative expenses 148.36%7.04M234.10%6.79M104.25%13.99M117.32%4.68M187.69%4.44M63.78%2.84M43.10%2.03M10.40%6.85M9.18%2.15M6.86%1.54M
-Selling and marketing expense 168.20%5.95M313.16%4.99M265.54%10.47M276.56%3.81M350.91%3.23M179.60%2.22M253.22%1.21M103.84%2.86M101.80%1.01M296.13%717K
-General and administrative expense 76.75%1.09M118.20%1.8M-11.72%3.52M-23.64%872K46.00%1.21M-34.36%615K-23.56%824K-16.97%3.98M-22.37%1.14M-34.60%826K
Research and development costs 65.37%425K-29.80%424K17.69%1.8M41.18%504K85.78%431K-44.13%257K26.62%604K9.08%1.53M14.79%357K9.95%232K
Operating profit 222.02%532K4.27%-1.21M39.31%-3.8M36.55%-894K-13.77%-1.21M77.95%-436K30.40%-1.27M16.23%-6.27M38.01%-1.41M34.73%-1.06M
Net non-operating interest income (expenses) 50.00%3K-155.56%-5K21.05%23K150.00%15K-142.86%-3K-81.82%2K280.00%9K246.15%19K146.15%6K7K
Non-operating interest income 0.00%3K--09.52%23K62.50%13K--0-72.73%3K--10K--21K--8K--7K
Non-operating interest expense ----400.00%5K--0-200.00%-2K--3K--1K-80.00%1K-84.62%2K--2K--0
Other net income (expenses) 2,265.79%899K-110.34%-3K-110.77%-254K26.92%297K-169.36%-618K-72.66%38K-97.35%29K190.80%2.36M-86.08%234K144.35%891K
Gain on sale of security 2,265.79%899K-110.34%-3K-110.77%-254K26.92%297K-169.36%-618K-72.66%38K-97.35%29K190.80%2.36M-86.08%234K144.35%891K
Income before tax 462.12%1.43M0.65%-1.22M-3.76%-4.03M50.21%-582K-1,027.78%-1.83M78.33%-396K-68.45%-1.23M61.47%-3.89M-93.22%-1.17M95.54%-162K
Income tax 478K234K21,300.00%214K21,300.00%214K0001K1K0
Earnings from equity interest net of tax
Net income 341.41%956K-18.40%-1.45M-9.23%-4.25M31.97%-796K-1,027.78%-1.83M78.33%-396K-68.45%-1.23M61.46%-3.89M-93.39%-1.17M95.54%-162K
Net income continuous operations 341.41%956K-18.40%-1.45M-9.23%-4.25M31.97%-796K-1,027.78%-1.83M78.33%-396K-68.45%-1.23M61.46%-3.89M-93.39%-1.17M95.54%-162K
Noncontrolling interests 399.19%619K645.24%313K461.60%452K135.14%87K3,233.33%200K236.26%124K153.85%42K-184.09%-125K212.12%37K154.55%6K
Net income attributable to the company 164.81%337K-39.13%-1.77M-24.87%-4.7M26.84%-883K-1,106.55%-2.03M70.05%-520K-95.08%-1.27M62.54%-3.76M-111.01%-1.21M95.36%-168K
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders 164.81%337K-39.13%-1.77M-24.87%-4.7M26.84%-883K-1,106.55%-2.03M70.05%-520K-95.08%-1.27M62.54%-3.76M-111.01%-1.21M95.36%-168K
Diluted earnings per share 150.00%0.0010.00%-0.005-6.25%-0.01740.00%-0.003-600.00%-0.00771.43%-0.002-66.67%-0.00568.00%-0.01616.67%-0.00593.75%-0.001
Basic earnings per share 150.00%0.0010.00%-0.005-6.25%-0.01740.00%-0.003-600.00%-0.00771.43%-0.002-66.67%-0.00568.00%-0.01616.67%-0.00593.75%-0.001
Dividend per share
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CA
Overall
Symbol
Latest Price
% Chg

No Data